Health Condition 1: null- Patients scheduled for unilateral total knee arthroplasty
Conditions
Interventions
Intervention1: 20 ml of 0.375% ropivacaine: 20 ml of 0.375% ropivacaine will be injected as a single dose into the adductor canal on the operated side by a 21 G 10 cm short bevel needle with a 25 cm l
Sponsors
Army Hospital Research and Referral Delhi
Eligibility
Inclusion criteria
Inclusion criteria: ASA I-III BMI 20-30 kg/m2 Patients scheduled for elective unilateral total knee arthroplasty
Exclusion criteria
Exclusion criteria: Contraindication to subarachnoid block or allergy to any of the study drugs; Known coagulopathy, local infection at block site; Patients in whom the nerve block could not be performed at per the procedure described in the methodology; Renal dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of post-operative analgesiaTimepoint: 24 hr | — |
Secondary
| Measure | Time frame |
|---|---|
| Any adverse effects , if anyTimepoint: 24 hr;Level of patient satisfactionTimepoint: At 24 hr;Success of early ambulation in terms of steps walked by the patient after surgeryTimepoint: 24 hr;Total 24 hr opioid consumption in the form of intravenous tramadolTimepoint: 24 hr | — |
Countries
India
Contacts
Public ContactRakhee Goyal
Army Hospital (Research and Referral), New Delhi, India
Outcome results
None listed